Sign in

Metabologia

@metabologiajnl.bsky.social
55 followers 13 following 55 posts

The EASD’s new open-access journal

PostsRepliesMedia
Metabologia @metabologiajnl.bsky.social · 01/10/2026
Metabologia wants your research papers on the #metabolic aspects of #diabetes, #obesity #CVD and #renal and #hepatic disease #comorbidity #nutrition #exercise #psychosocial #healtheconomics #healthtechnology – submit now! metabologia.org #EASD2026
031
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 01/10/2026
👋 𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐦𝐞𝐭 𝐭𝐡𝐞 𝐏𝐫𝐞𝐬𝐢𝐝𝐞𝐧𝐭 𝐲𝐞𝐭? 𝐂𝐨𝐦𝐞 𝐬𝐚𝐲 𝐡𝐢! EASD members - join us for a Meet & Greet with EASD President Francesco Giorgino. 📅 𝐓𝐎𝐃𝐀𝐘, 01 Oct 2026 | 🕒 15:15 - 16:15 CEST | 📍 EASD Member Lounge Drop by, say hello & connect with fellow members at #EASD2026!
041
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 30/09/2026
🏆 Don't miss the #RisingStar Symposium at #EASD2026 chaired by Prof. Matthias Blüher! This year's awardees will present their work: 🎤 Dr Aaron Novikoff 🇩🇪 🎤 Dr Carla Horvath 🇨🇭 🎤 Dr Sara Stinson 🇳🇴 🎤 Dr Nick Thomas 🇬🇧 📅 Thurs, 1 Oct 2026 | 🕣 08:30 - 10:10 CEST |📍Paris Hall Congratulations to them all!
042
Metabologia @metabologiajnl.bsky.social · 01/10/2026
Adults with single islet #autoantibodies who develop diabetes don’t all follow same path; some need early #insulin, others don't. 2026 #EASD/#EFSD Rising Star Nicholas Thomas’ research investigates who’s at greatest risk of needing insulin & how to predict this link.springer.com/article/10.1...
link.springer.com
Rising Star 2026: Understanding and identifying adult-onset type 1 diabetes: from disease classification to early-stage intervention - Metabologia
Metabologia -
131
Metabologia @metabologiajnl.bsky.social · 30/09/2026
An absolutely packed Metabologia Spotlight session underway #easd2026 with Editor Jennifer Sargent, and Associate Editors Nicholas Chew, Sara Suliman and Sami Qadri
020
Metabologia @metabologiajnl.bsky.social · 30/09/2026
On the spotlight stage today 12-12.45 #easd2026 Metabologia symposium The emerging cardiovascular-kidney-liver-metabolic (CKLM) interplay: from population health to targeted therapies. Chaired by editor Jennifer Sargent, and panellists from the journal’s editorial board
010
Metabologia @metabologiajnl.bsky.social · 30/09/2026
Metabologia wants your research papers on the #metabolic aspects of #diabetes, #obesity, #CVD and #renal and #hepatic disease #comorbidity #nutrition #exercise #psychosocial #healtheconomics #healthtechnology – submit now! metabologia.org #EASD2026
metabologia.org
Metabologia – Journal of the European Association for the Study of Diabetes (EASD)
011
Metabologia @metabologiajnl.bsky.social · 29/09/2026
Francesco Giorgino et al provide perspectives from the @easdnews.bsky.social Global Council for a collaborative genomics platform for type 1 #diabetes spanning #Ukraine and #Poland in @metabologiajnl.bsky.social link.springer.com/article/10.1...
link.springer.com
The value of building a resilient genomic network for type 1 diabetes in under-represented regions - Metabologia
Metabologia -
132
Metabologia @metabologiajnl.bsky.social · 29/09/2026
Submit to #Metabologia! One of EASD official journals and open to research papers on the #metabolic aspects of #diabetes, #obesity, #CVD and #renal and #hepatic disease #comorbidity #nutrition #exercise #psychosocial #healtheconomics #healthtechnology
010
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 08/09/2026
🧠 How does the nervous system help build the pancreas? Meet Associate Prof. Pia Nyeng, recipient of the #EFSD Anniversary Fund Programme. Her research explores how pancreatic neurons may guide organ development & beta-cell formation. 📖 journals.biologists.com/dev/article/...
043
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 09/09/2026
❓How will #AI and #wearables shape the future of metabolic and cardiovascular risk assessment and care? Anca Pantea Stoian points out highlights from the @escardio.bsky.social and EASD Joint Session at the #ESCCongress 2026. Watch here👉 easd-elearning.eu/news/480/Fro...
043
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 15/09/2026
🧠Meet Matthew Johnson (@exeter.ac.uk), #EFSD Rising Star Fellowship recipient. He uses genome sequencing to identify genetic causes of early-onset #diabetes, contributing to the discovery of 3 #genes linked to monogenic autoimmune diabetes: PD-L1, RNU4ATAC & RNU6ATAC. 📖 rupress.org/jem/article/...
Slide with teal and blue geometric background and green circular accents. Title text reads "Recipient Research Portrait..." with subheading "Doctor Matthew Johnson, University of Exeter, UK." A circular photo shows a smiling man with short brown hair wearing a dark blue collared shirt and a lanyard. The EFSD (European Foundation for the Study of Diabetes) logo appears at the bottom.Slide with light blue background and dark blue circular accents. Headline text on a teal banner reads "Identifying novel genetic causes of diabetes to give insights into mechanisms of beta cell autoimmunity." Below, on a green banner, body text explains that Matthew Johnson uses genome sequencing of families with extreme early-onset diabetes to search for previously unknown genetic causes of diabetes, with each new gene discovered offering insight into how the immune system attacks insulin-producing beta cells and pointing toward new therapeutic targets. The EFSD logo appears at the bottom.Slide with light blue background and curved blue/teal line accents. Text reads "Supported by the EFSD Rising Star Research Fellowship, Supported by Novo Nordisk." Below, on a dark navy banner, bold white text reads "Apply for research grants and fellowships" with the URL "europeandiabetesfoundation.org" underneath.
043
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 21/09/2026
🚨Applications for the EASD Albert Renold Travel Fellowship 2026 are still open! ≤ €10,000 for early-career researchers to undertake research visits abroad to learn skills to advance their #diabetes research. 📅 Deadline: 02 Nov |🕛12:00 pm CEST 🔗👉 www.europeandiabetesfoundation.org/programmes/p...
Promotional graphic for the EASD Albert Renold Travel Fellowship Programme. It features a “Call for Applications” banner and explains that the programme enables scientists and clinicians to advance their diabetes research projects by learning specific techniques or clinical skills at other institutions. A laboratory image showing test tubes and a pipette appears within circular graphic elements on the right. The EFSD logo and europeandiabetesfoundation.org are displayed at the bottom.
033
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 22/09/2026
🧠 Meet Dr. Mostafa Bakhti (@helmholtzmunich.bsky.social), #EFSD & #Lilly 🇪🇺 Diabetes Research Programme award recipient. His work explores how β-cell cytoskeleton regulates insulin secretion. 📖 Learn more: www.helmholtz-munich.de/en/idr/news-... Supported by Lilly Diabetes International.
Recipient Research Portrait…' slide with a circular photo of Dr Mostafa Bakhti, smiling, wearing glasses and a checked shirt. Text below reads 'Doctor Mostafa Bakhti, Helmholtz Munich, Germany.' EFSD logo at the bottomSlide titled 'Decoding tubulin code in beta cells: The role of acetylated tubulin and HDAC6 in regulating insulin secretion.' Text below explains that Mostafa Bakhti's research explores how the cytoskeleton of insulin-producing beta cells controls insulin release, aiming to uncover new ways to restore beta cell function in diabetes. EFSD logo at the bottom.Slide reading 'Supported by the EFSD and Lilly European Diabetes Research Programme.' Below, bold text reads 'Apply for research grants and fellowships,' with the website europeandiabetesfoundation.org.
052
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 23/09/2026
🥕Low #BMI but a high #HbA1c? The International Diabetes Federation's President, Prof. Peter Schwarz describes the still-evolving classification of #T5D, a long-neglected type of #diabetes linked to malnutrition. 👉📺 Watch here: 🔗 easd-elearning.eu/episode/380/...
022
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 24/09/2026
🎥🇮🇹 Ahead of #EASD2026, President Francesco Giorgino spoke with Touch Endocrinology about the key developments to watch in Milan. He also shares his vision for EASD & putting People Living with #Diabetes at the centre of #care. 🔗👉 Read the full interview: lnkd.in/p/eV5kPRvM
lnkd.in
#easd2026 #easd2026 #diabetes #diabetesresearch #diabetescare #endocrinology | Touch Medical Media
🩺 What are the key themes to watch at #EASD2026? Ahead of the EASD 2026 Annual Meeting in Milan, touchENDOCRINOLOGY spoke with EASD President Prof. Francesco Giorgino about the developments shaping d...
034
Reposted by Metabologia
Diabetologia @diabetologiajnl.bsky.social · 22/09/2026
Freedom of speech is essential for rigour in scientific publishing. In Diabetologia, we provide a platform for the editors of Diabetes Care and the ADA leadership to present their perspectives on events following the ADA Scientific Sessions in June link.springer.com/article/10.1...
link.springer.com
Standing together for diabetes - Diabetologia
Diabetologia -
033
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 18/09/2026
The latest issue of @diabetologiajnl.bsky.social is now available! New articles covering the latest in diabetes research. 🔗👉 Read the full issue here: link.springer.com/journal/125/... #DiabetesResearch #Diabetes #EASD2026 #medicaljournal
043
Reposted by Metabologia
Diabetologia @diabetologiajnl.bsky.social · 17/09/2026
Comment by Ng highlights 4 @metabologiajnl.bsky.social & Diabetologia papers, tracing an evidence-based pathway incl. a synthesis of interventions & programmes addressing #DiabetesDistress &, uniquely, perspectives of those with #LivedExperience. #diabetes #clinicalguidelines @easdnews.bsky.social
121
Metabologia @metabologiajnl.bsky.social · 17/09/2026
Comment by Ng highlights 4 Metabologia & @diabetologiajnl.bsky.social papers, tracing an evidence-based pathway incl. a synthesis of interventions & programmes addressing #DiabetesDistress &, uniquely, perspectives of those with #LivedExperience. #diabetes #clinicalguidelines @easdnews.bsky.social
132
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 15/09/2026
📣 Join us for our next EASD Early Career Academy #webinar with Prof. Fredrik Bäckhed discussing how gut microbiota changes drive metabolic dysfunction & microbial metabolites as key mediators & therapeutic targets in #diabetes. 📅 15 Oct 2026 | 🕛 16:00 CEST 🔗👉 us06web.zoom.us/webinar/regi...
EASD Early Career Academy Webinar Series announcement. Date: 15 October 2026, 16:00 CEST. Guest: Prof. Fredrik Bäckhed, Sweden. Topic: The Gut Microbiota in Cardiometabolic Disease: Mechanisms and Metabolic Mediators. Blue gradient background with EASD logo and easd.org/academy link.
144
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 26/08/2026
✋Young adults with newly diagnosed #T2D may be far less active than their peers: At age 20, estimated moderate-to-vigorous activity was 16 vs 49 min/day. New findings reinforce the need for tailored lifestyle interventions. 👉Read more: easd-elearning.eu/news/478/Typ...
032
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 31/08/2026
📢 Applications are open for the Albert Renold Travel #Fellowship. Boost your #research journey with: ✅ Up to €10,000 ✅ Research stay - 3 months ✅ Exchange with top EU institutions 📅 Application deadline: 02 Nov 2026 | 🕛 12:00 CET Apply now 👉 www.europeandiabetesfoundation.org/programmes/p...
033
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 01/09/2026
🧠 Meet Prof. Oluf Pedersen, #EFSD research grant recipient. His first-in-human study of the bacterial hormone RORDEP1 found effects on GIP, GLP-1 and insulin sensitivity, opening new avenues for research into the gut microbiome and metabolic disease. 📖 www.nature.com/articles/s41... #funding
153
Reposted by Metabologia
Sami Qadri @samiqadri.bsky.social · 31/08/2026
Looking forward to #EASD2026 where I'm honored to give these talks: - 29/9: "Finding MASLD: Smarter Screening in Today’s Clinics" - 30/9: "MASLD, T2D, and the CKLM framework" - 1/10: "Screening and diagnosis of MASLD in diabetes" @metabologiajnl.bsky.social @diabetologiajnl.bsky.social
052
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 25/08/2026
🧠 Meet Prof. John Dennis,recipient of the #EFSD Rising Star Research #Fellowship. His research develops prediction models to estimate which people with Type 2 #Diabetes are most likely to benefit from SGLT2 inhibitors for #kidney protection. 📖👉 link.springer.com/article/10.1... #PrecisionMedicine
Teal, blue, and green graphic titled "Recipient Research Portrait…" featuring a circular headshot of Professor John Dennis, a smiling man with grey hair wearing a white collared shirt. Text reads "Professor John Dennis, University of Exeter, UK." EFSD (European Foundation for the Study of Diabetes) logo in the bottom banner.Teal and green graphic with the heading "Individual-level cardiovascular and heart failure risk stratification to inform precision SGLT2-inhibitor treatment." Body text explains that SGLT-2 inhibitors reduce heart failure risk and chronic kidney disease progression in people with type 2 diabetes, but most people with type 2 diabetes don't have these conditions, and that John Dennis' research aims to develop a model identifying who would most likely benefit from SGLT2-inhibitor therapy for prevention of heart failure and kidney disease. EFSD logo in the bottom banner.Blue graphic reading "Supported by the EFSD Rising Star Research Fellowship, Supported by Novo Nordisk." Below, a dark blue banner reads "Apply for research grants and fellowships, europeandiabetesfoundation.org."
043
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 11/08/2026
🧠Meet Dr. Shai Fuchs, recipient of the #EFSD / Boehringer Ingelheim 🇪🇺 Research Programme on “Multi-System Challenges in #Diabetes”. His project explores how gut hormone GLP-2 affects liver cells & gut-liver links in disease. 📖 doi.org/10.1172/jci.... 💡 www.europeandiabetesfoundation.org/programmes/
032
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 12/08/2026
📢 𝐖𝐄'𝐑𝐄 #𝐇𝐈𝐑𝐈𝐍𝐆: We are seeking an Administrator (m/f/d) for our Education Department (full-time). 🗓️ Deadline: 31 Aug 2026. If you're organised, detail-oriented & keen to support diabetes education initiatives - this could be for you! 🔗👉 Learn more & apply now: www.easd.org/uploads/JobA...
043
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 18/08/2026
🧠 Meet Dr. Daniel Coral, recipient of the #EFSD & #Lilly European #Diabetes #Research Programme. His work models eGFR trajectories to dissect CKD heterogeneity in #type2diabetes. 📖 Read: www.nature.com/articles/s41... 🔗Apply by 1 September 2026 : www.europeandiabetesfoundation.org/programmes/p...
EFSD Recipient Research Portrait graphic on a blue and green background with circular design elements. A smiling photo of Doctor Daniel E. Coral, based at Lund University, Sweden, appears in a circular frame. EFSD logo at the bottom.Text graphic on a blue and green background titled 'Modelling of eGFR trajectories to dissect CKD heterogeneity and response to treatment.' Body text reads: Daniel E. Coral uses nonlinear modelling of repeated kidney-function measurements to identify distinct patterns of renal decline after type 2 diabetes diagnosis. By linking these trajectories to clinical and molecular characteristics, he aims to improve early risk stratification and support more personalised prevention and treatment of chronic kidney disease. EFSD logo at the bottom.Text graphic on a light blue background reading 'Supported by the EFSD and Lilly European Diabetes Research Programme.' Below, in a dark blue box: 'Apply for research grants and fellowships' with the website europeandiabetesfoundation.org.
043
Metabologia @metabologiajnl.bsky.social · 20/08/2026
Meet our editorial board metabologia.org/editorial-board/ with expertise across various fields relating to diabetes and its complications, obesity, and metabolic aspects of other conditions - and all waiting for your submissions!
142
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 13/08/2026
📖 The latest issue of @diabetologiajnl.bsky.social is now available! New articles covering the latest in diabetes #research. 🔗👉 Read the full issue here: link.springer.com/journal/125/... #Diabetes #EASD2026 #medicaljournal @springernature.com @springermedicine.com @hinmul.bsky.social
084
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 11/08/2026
🆕 Should patients wait months on lifestyle changes alone before accessing #obesity medications? A new @metabologiajnl.bsky.social Perspective makes the case for starting both together, in step with current international #guidelines. 👏 Well worth a read 🔓: link.springer.com/article/10.1...
072
Metabologia @metabologiajnl.bsky.social · 10/08/2026
New @metabologiajnl.bsky.social Perspective: should people wait 6 months on lifestyle intervention before accessing obesity management medications? We argue for concomitant initiation, in line with recent international guidelines. #ObesityCare #ObesityMedications link.springer.com/article/10.1... 🔓
link.springer.com
Is mandatory lifestyle intervention before pharmacological obesity management needed? - Metabologia
Many clinical guidelines require a period of lifestyle intervention before initiating obesity management medications. No prospective trial has tested whether this sequence improves outcomes compared w...
031
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 31/07/2026
🎙️ Does it matter when you #exercise? Dr Jeroen van der Velde (Leiden University Medical Center) discusses the latest evidence on exercise timing, circadian rhythms & type 2 #diabetes. Could exercising later in the day improve glycaemic control? 🎧👉 Listen now: www.easd.org/media-centre...
032
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 07/08/2026
🚨REMINDER: Applications are now open for the EASD Albert Renold Travel Fellowship 2026: ⏳Deadline: 02 November 2026 (12:00 CEST) 🌍For #earlycareer scientists/clinicians in 🇪🇺 or EU-associated countries. 💶Up to €10,000 Apply via the #EFSD Portal ➡️ www.europeandiabetesfoundation.org/programmes/p...
043
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 04/08/2026
🧠Meet Alessandro Mengozzi (University of Pisa), recipient of the #EFSD Rising Star Research Fellowship. His research explores how long non-coding RNAs could predict early beta-cell dysfunction, paving the way for earlier #diabetes prevention. 🔗👉 Apply now: www.europeandiabetesfoundation.org/home/
Portrait card on a teal, blue and green background with the EFSD logo. Text reads "Recipient Research Portrait..." above a circular headshot of a smiling man with dark curly hair, wearing a white lab coat and burgundy tie. Below: "Assistant Professor Alessandro Mengozzi, University of Pisa, Italy."Blue background with a green text box. Heading reads "Long non-coding RNAs as direct modulators of beta cell function: a translational study." Below it: "Alessandro Mengozzi investigates whether and how long non-coding RNAs (lncRNAs), which contain early epigenetic information, can predict beta-cell dysfunction at its earliest stages." EFSD logo in the bottom corner.Blue background with green and dark navy text blocks and the EFSD ribbon graphic. Text reads "Supported by the EFSD Rising Star Research Fellowship, supported by Novo Nordisk." Below, in bold white text: "Apply for research grants and fellowships," followed by the URL "europeandiabetesfoundation.org."
033
Metabologia @metabologiajnl.bsky.social · 31/07/2026
Phil Ambery et al explore PTEN’s role in metabolic regulation and consider if established medicines for T2D and obesity could be used for the metabolic and other features of PTEN hamartoma tumour syndrome. The work was supported by PTEN Research link.springer.com/article/10.1... 🔓
link.springer.com
Metabolism in PTEN hamartoma tumour syndrome - Metabologia
PTEN hamartoma tumour syndrome (PHTS) is an inherited syndrome caused by germline loss of function of the phosphatase and tensin homologue (PTEN) tumour suppressor gene. This causes cancer predisposit...
021
Metabologia @metabologiajnl.bsky.social · 30/07/2026
Study explores 24-h physical behaviours across age at diagnosis in individuals with type 2 diabetes link.springer.com/article/10.1... 🔓
link.springer.com
Age at diagnosis of type 2 diabetes and accelerometer-assessed 24-h physical behaviours: a cross-sectional pooled analysis - Metabologia
Aims/hypothesis We investigated the association between age at diagnosis of type 2 diabetes and accelerometer-assessed 24-h physical behaviours. Methods This cross-sectional study pooled data from thr...
032
Metabologia @metabologiajnl.bsky.social · 29/07/2026
Precision diabetes medicine could reduce health disparities. In this scoping review (34 studies), Paul Franks and colleagues examine how health equity is addressed in the literature, highlighting the need for equity to be built in from the outset link.springer.com/article/10.1... 🔓
link.springer.com
Precision diabetes medicine and health equity: a scoping review - Metabologia
Aims/hypothesis Precision diabetes medicine aims to improve the accuracy of prevention and treatment by tailoring care to individuals and subgroups. When applied appropriately, it can reduce health di...
043
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 14/07/2026
🎥 Catch up on the EASD Early Career Academy #webinar on " @metabologiajnl.bsky.social - Introducing EASD's New Journal" w. Jennifer Sargent & Simon Dreher is now online covering the journal's vision, scope & submission process. Watch now👉 www.youtube.com/watch?v=XHAN... NB: Open for submissions!
Blue promotional graphic for the EASD Early Career Academy Webinar Series. Bold white heading reads "Webinar Series" with the EASD logo in the top right corner. Below, three labelled rows give the event details; Date - 2 July 2026, 16:00 CEST; Guests - Dr. Jennifer Sargent, Editor-in-Chief, and Dr. Simon Dreher, Associate Editor; Topic - "Metabologia - Introducing EASD's New Journal." The EASD Early Career Academy logo appears bottom left, with the web address easd.org/academy bottom right.
033
Metabologia @metabologiajnl.bsky.social · 10/07/2026
Metabologia - how do you say it? 🤔😄 Watch again our video made at #EASD2025 youtu.be/ZJsk3oR9AlE?...
youtu.be
Metabologia - how do you say it?
YouTube video by Metabologia
010
Metabologia @metabologiajnl.bsky.social · 10/07/2026
Metabologia is an open access journal dedicated to advancing high-quality research across the fields of #diabetes, #obesity, #metabolism and related disorders. We are open for submissions! Go to metabologia.org for more info
metabologia.org
Metabologia – Journal of the European Association for the Study of Diabetes (EASD)
010
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 09/07/2026
📖 The #August issue of @diabetologiajnl.bsky.social, the official journal of EASD, is now available. Explore the latest diabetes research 👇 #DiabetesResearch #Diabetologia #MedicalJournal
043
Reposted by Metabologia
Sami Qadri @samiqadri.bsky.social · 03/07/2026
Very excited to take on this role! Thank you @metabologiajnl.bsky.social and Dr. Jennifer Sargent for the trust – I’m looking forward to working with the editorial team to help make this journal a home for top-quality metabolic research from colleagues around the world.
031
Metabologia @metabologiajnl.bsky.social · 01/07/2026
Meet our Editorial Board here metabologia.org/editorial-bo... - ready for your submissions!
Picture of Sami and the text: Sami F. Qadri
Helsinki University Hospital, Finland
"My research seeks to unravel the bidirectional relationship between steatotic liver disease (MASLD/MASH) and systemic metabolic health. I believe rigorous, innovative clinical investigation holds the key to breakthroughs in treating chronic conditions. I am delighted to join Metabologia and help establish it as a premier journal for human-centric, high-impact metabolic research."
041
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 29/06/2026
⏰3 days left to register! Join the EASD Early Career Academy #webinar with Dr. Jennifer Sargent (Editor-in-Chief) & Dr. Simon Dreher (Associate Editor) introducing @metabologiajnl.bsky.social, EASD's new journal. 📅Thurs, 2 July 2026 | 🕛 16:00 CEST 🔗👉 Register now: us06web.zoom.us/webinar/regi...
Blue gradient graphic titled "Webinar Series" with the EASD logo in the top right. Three info bars list: Date - 2 July 2026, 16:00 CEST; Guests - Dr. Jennifer Sargeant, Editor-in-Chief, and Dr. Simon Dreher, Associate Editor; Topic - Metabologia: Introducing EASD's New Journal. The EASD Early Career Academy logo appears bottom left, with the URL easd.org/academy bottom right.
022
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 19/06/2026
🎉 Proud to highlight EASD Early Career Academy committee member Dr. Sini Heinonen (University of Helsinki), who's joined @metabologiajnl.bsky.social as an associate editor! 📢✍️ Metabologia is open for submissions! Explore the submission guidelines & share your #research: metabologia.org #Diabetes
044
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 16/06/2026
🧠Meet Dr. Ben A. Kappel recipient of the #EFSD & Sanofi European Diabetes Research Programme in #CVD. He investigates how #T2D alters cardiac #metabolism & contributes to heart failure with preserved ejection fraction (HFpEF). 📄 Under preparation 💡 www.europeandiabetesfoundation.org
033
Metabologia @metabologiajnl.bsky.social · 15/06/2026
Meet Metabologia's editorial board, ready for your submissions! metabologia.org/editorial-bo...
Photo of Sini Heinonen and quote 'Driven by a fascination with human metabolic biology, my research focuses on obesity, adipose tissue function, mitochondrial metabolism, and translational studies of metabolic disease. I am honoured to join the editorial board and contribute to the quality and integrity of research in the field, helping to advance our understanding of metabolic health and disease.'
010
Reposted by Metabologia
European Association for the Study of Diabetes @easdnews.bsky.social · 09/06/2026
🧠Meet Emma Ahlqvist, recipient of the #EFSD "New Targets for #Diabetes/ #Obesity related Metabolic Diseases" grant. Her research combines genomics & 3D human muscle organoids to identify new pathways driving diabetes & insulin resistance. 📄 Stay tuned 💡 www.europeandiabetesfoundation.org/programmes/
Recipient Research Portrait graphic featuring a circular headshot of Dr Emma Ahlqvist, a woman with red curly hair wearing a dark blazer. Text reads: "Recipient Research Portrait… Doctor Emma Ahlqvist, Lund University, Sweden." EFSD - European Foundation for the Study of Diabetes logo appears at the bottom.EFSD graphic displaying the title of Dr Emma Ahlqvist's research project: "A translational approach to identification of novel targets for treatment of diabetes and muscle insulin-resistance." A summary reads: Emma Ahlqvist uses large-scale genetic and clinical data to identify new biological pathways involved in diabetes and insulin resistance. By integrating GWAS, polygenic scores, and functional studies, she aims to uncover novel therapeutic targets for improving metabolic health. EFSD logo appears at the bottom.EFSD graphic stating that Dr Ahlqvist's research is supported by the EFSD "New Targets for Diabetes or Obesity-related Metabolic Diseases" Programme, supported by an educational research grant from MSD. A call to action reads: "Apply for research grants and fellowships – europeandiabetesfoundation.org."
042